Syneos Health Appoints Costa Panagos as Chief Executive Officer
09. Oktober 2024 09:00 ET
|
Syneos Health, Inc.
Colin Shannon Appointed Executive Chairman Seasoned Executive Further Strengthens Company’s Leadership Team MORRISVILLE, N.C., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Syneos Health®, a leading fully...
Syneos Health Leaders Recognized as PM360 ELITE 100 Award Recipients
23. Mai 2024 10:53 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 23, 2024 (GLOBE NEWSWIRE) -- Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, today announced PM360 has named six distinguished colleagues...
Syneos Health and uMotif Partner to Deliver Patient-centric eClinical Platform
26. Juni 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., June 26, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health Equity
25. Mai 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 25, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Batisha...
Syneos Health Leaders Recognized by HBA
17. Mai 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 17, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced that Jennifer Sozio, SVP...
Syneos Health Leaders Recognized as PM360 2023 ELITE Award Recipients
16. Mai 2023 08:05 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced PM360 has named Maria Fotiu,...
Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023
13. April 2023 16:31 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 13, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, will release its first quarter 2023 financial...
Syneos Health Wins 2023 ViE Award
05. April 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced it has been awarded...
Syneos Health Reports Fourth Quarter and Full Year 2022 Results
16. Februar 2023 06:03 ET
|
Syneos Health, Inc.
Revenue for the fourth quarter of $1,359.9 million decreased 1.0% on a reported basis and increased 1.7% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
03. Januar 2023 16:31 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...